In Brief This Week: GenMark, Advanced Liquid Logic, Illumina; Quest, Transgenomic; Cancer Genetics; PerkinElmer, Caliper, Bruker; More | GenomeWeb

NEW YORK (GenomeWeb News) – Following Illumina's purchase of Advanced Liquid Logic in July, GenMark has liquidated its preferred stock investment in ALL but retained its license to the firm's digital microfluidics technology, GenMark said in its Form 10-Q filed with the US Securities and Exchange Commission this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.